DRW Holdings »

Corvus Pharmaceuticals shares owned by DRW Holdings

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by DRW Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $180k 23k 7.70

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Bitcoin Trust Etf Common Call Option (IBIT)
Tesla Motors Call Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Apple Call Option (AAPL)
Astrazeneca Sponsored Adr Call Option
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
NVIDIA Corporation Call Option (NVDA)
Qualcomm Call Option (QCOM)
Freeport-mcmoran CL B Call Option (FCX)
Spdr Gold Tr Gold Shs (GLD)
Ishares Msci Taiwan Etf (EWT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)

View all positions for DRW Holdings

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Perceptive Advisors
Foresite Capital Management VI
DCF Advisers
Susquehanna International
Goldman Sachs Group
Logos Global Management

View all funds holding Corvus Pharmaceuticals